AURA · Aura Biosciences Inc
United States · RS rating 41 · As of 2026-11-03
| Price | 6.24 USD |
|---|---|
| 1-day change | +3.5% |
| RS rating (overall / 1M / 3M / 12M) | 41 / 58 / 40 / 52 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 24 / 25 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +4.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +29.9% |
| Market cap (USD) | $466.1M |